Open Philanthropy Project Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2018
NCT03389555
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Open Philanthropy Project

Active Ingredients

Drugs in Phase 3 Trials (3)

hydrocortisone (solu-cortef) (1 trial)

thiamine (1 trial)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sepsis (Phase 3)

Shock, Septic (Phase 3)

Toxemia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3